Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Goodfellow Gems #178
Wednesday 31 August 2022, 12:33 AM

[Image: Robina Weermeijer on Unsplash]
“Chronic kidney disease and SGLT2 inhibitors”
A July 2022 Tools for Practice notes that some sodium-glucose cotransporter-2 inhibitors are helpful for patients with end-stage kidney disease (ESKD)
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
tinyurl.com/ToolsForPractice319 (Tools for Practice #319, 12 July 2022).